Synapse - Andrew Plodkowski

Results (44)

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Journal Article

Memon, D.; Schoenfeld, A. J.; Ye, D.; Fromm, G.; Rizvi, H.; Zhang, X.; Keddar, M. R.; Mathew, D.; Yoo, K. J.; Qiu, J.; more...
Cancer Cell (2024)

Fulltext@MSK | Save

Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer

Journal Article

Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
The Oncologist (2023)

Fulltext@MSK | Save

Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer

Journal Article

Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer

Journal Article

Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer

Meeting Abstract

Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228

Journal Article

Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas

Journal Article

Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Journal Article

Pai, J. A.; Hellmann, M. D.; Sauter, J. L.; Mattar, M.; Rizvi, H.; Woo, H. J.; Shah, N.; Nguyen, E. M.; Uddin, F. Z.; Quintanal-Villalonga, A.; more...
Cancer Cell (2023)

Fulltext@MSK | Save

Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors